{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:41:45Z","timestamp":1790347305084,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T00:00:00Z","timestamp":1292284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1000377","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T16:03:06Z","timestamp":1292342586000},"page":"e1000377","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":119,"title":["Antibiotic Selection Pressure and Macrolide Resistance in Nasopharyngeal Streptococcus pneumoniae: A Cluster-Randomized Clinical Trial"],"prefix":"10.1371","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct00322972","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Alison H.","family":"Skalet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Cevallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berhan","family":"Ayele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teshome","family":"Gebre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulat","family":"Zerihun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dereje","family":"Habte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yared","family":"Assefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Emerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Gaynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis C.","family":"Porco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Lietman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy D.","family":"Keenan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,12,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3201\/eid0804.010312","article-title":"Antimicrobial use and antimicrobial resistance: a population perspective.","volume":"8","author":"M Lipsitch","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)70799-6","article-title":"Outpatient antibiotic use in Europe and association with resistance: a cross-national database study.","volume":"365","author":"H Goossens","year":"2005","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3201\/eid0803.010192","article-title":"A European study on the relationship between antimicrobial use and antimicrobial resistance.","volume":"8","author":"SL Bronzwaer","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1128\/AAC.01581-06","article-title":"Risk factors for development of multiple-class resistance to Streptococcus pneumoniae Strains in Belgium over a 10-year period: antimicrobial consumption, population density, and geographic location.","volume":"51","author":"J Van Eldere","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1089\/mdr.2006.12.158","article-title":"Antibacterial use and Streptococcus pneumoniae penicillin resistance: a temporal relationship model.","volume":"12","author":"RM Mera","year":"2006","journal-title":"Microb Drug Resist"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1089\/mdr.2006.12.169","article-title":"The role of antimicrobial use in the epidemiology of resistant pneumococci: a 10-year follow up.","volume":"12","author":"VA Arason","year":"2006","journal-title":"Microb Drug Resist"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199907223410403","article-title":"Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.","volume":"341","author":"DK Chen","year":"1999","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1086\/322735","article-title":"Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.","volume":"33","author":"M Pihlajamaki","year":"2001","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/jac\/46.6.959","article-title":"Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997).","volume":"46","author":"JJ Granizo","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1086\/383309","article-title":"Effect of macrolide consumption on erythromycin resistance in Streptococcus pyogenes in Finland in 1997-2001.","volume":"38","author":"M Bergman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/bmj.313.7054.387","article-title":"Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study.","volume":"313","author":"VA Arason","year":"1996","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1086\/429242","article-title":"Predicting antimicrobial resistance in invasive pneumococcal infections.","volume":"40","author":"OG Vanderkooi","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3201\/eid1708.060017","article-title":"Macrolide resistance in adults with bacteremic pneumococcal pneumonia.","volume":"12","author":"JP Metlay","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1001\/archinte.159.20.2461","article-title":"The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.","volume":"159","author":"Y Carmeli","year":"1999","journal-title":"Arch Intern Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/AAC.48.6.1934-1940.2004","article-title":"The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported.","volume":"48","author":"MK Bolon","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/S0140-6736(08)60836-3","article-title":"Trachoma.","volume":"371","author":"HR Wright","year":"2008","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jama.292.6.721","article-title":"Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.","volume":"292","author":"M Melese","year":"2004","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.299.7.778","article-title":"Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma.","volume":"299","author":"M Melese","year":"2008","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/8451","article-title":"Global elimination of trachoma: how frequently should we administer mass chemotherapy?","volume":"5","author":"T Lietman","year":"1999","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3201\/eid1507.081563","article-title":"Lack of macrolide resistance in Chlamydia trachomatis after mass azithromycin distributions for trachoma.","volume":"15","author":"KC Hong","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1128\/AAC.49.11.4804-4806.2005","article-title":"Impact of mass distribution of azithromycin on the antibiotic susceptibilities of ocular Chlamydia trachomatis.","volume":"49","author":"AW Solomon","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/clinids\/24.3.356","article-title":"A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae.","volume":"24","author":"AJ Leach","year":"1997","journal-title":"Clin Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/bjo.2005.068981","article-title":"Topical ocular antibiotics induce bacterial resistance at extraocular sites.","volume":"89","author":"BD Gaynor","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1086\/341414","article-title":"Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.","volume":"35","author":"AM Fry","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0140-6736(09)60323-8","article-title":"Assessment of herd protection against trachoma due to repeated mass antibiotic distributions: a cluster-randomised trial.","volume":"373","author":"JI House","year":"2009","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-3156.1997.d01-211.x","article-title":"Trachoma in Jimma zone, south western Ethiopia.","volume":"2","author":"N Zerihun","year":"1997","journal-title":"Trop Med Int Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/JCM.39.3.1021-1024.2001","article-title":"Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies.","volume":"39","author":"KL O'Brien","year":"2001","journal-title":"J Clin Microbiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/dkf806","article-title":"Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999\u20132000 study.","volume":"50","author":"DJ Farrell","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/JCM.42.2.764-768.2004","article-title":"Molecular epidemiology of multiresistant Streptococcus pneumoniae with both erm(B)- and mef(A)-mediated macrolide resistance.","volume":"42","author":"DJ Farrell","year":"2004","journal-title":"J Clin Microbiol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/AAC.35.7.1267","article-title":"Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification.","volume":"35","author":"R Leclercq","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1128\/AAC.40.8.1817","article-title":"Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.","volume":"40","author":"J Sutcliffe","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1128\/AAC.40.11.2562","article-title":"Detection of erythromycin-resistant determinants by PCR.","volume":"40","author":"J Sutcliffe","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/655697","article-title":"The decline of pneumococcal resistance after cessation of mass antibiotic distributions for trachoma.","volume":"51","author":"S Haug","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM199708143370701","article-title":"The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.","volume":"337","author":"H Seppala","year":"1997","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1086\/432721","article-title":"Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae.","volume":"41","author":"D Guillemot","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(07)60235-9","article-title":"Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study.","volume":"369","author":"S Malhotra-Kumar","year":"2007","journal-title":"Lancet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2009.1266","article-title":"Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.","volume":"302","author":"TC Porco","year":"2009","journal-title":"JAMA"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/bjo.87.2.147","article-title":"Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.","volume":"87","author":"BD Gaynor","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1128\/AAC.47.9.2765-2769.2003","article-title":"Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae.","volume":"47","author":"SL Batt","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1056\/NEJMoa040979","article-title":"Mass treatment with single-dose azithromycin for trachoma.","volume":"351","author":"AW Solomon","year":"2004","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1167\/iovs.06-0625","article-title":"Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.","volume":"48","author":"SK West","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ophtha.2009.04.041","article-title":"Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.","volume":"116","author":"JB Biebesheimer","year":"2009","journal-title":"Ophthalmology"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1086\/315382","article-title":"Increased carriage of trimethoprim\/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine\/pyrimethamine.","volume":"181","author":"DR Feikin","year":"2000","journal-title":"J Infect Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/506941","article-title":"Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers.","volume":"43","author":"PC Hill","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref45","first-page":"477","article-title":"A simple system for the assessment of trachoma and its complications.","volume":"65","author":"B Thylefors","year":"1987","journal-title":"Bull World Health Organ"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1000377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T22:33:58Z","timestamp":1559860438000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1000377"}},"subtitle":[],"editor":[{"given":"Steven M.","family":"Opal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,14]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1000377","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.7903957.8261055","asserted-by":"object"}]},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,14]]}}}